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Abstract
Rho GTPases, such as Rho, Rac and Cdc42, are known to regulate many cellular processes including cell movement and cell adhesion.
While the cellular events of germ cell movement are crucial to spermatogenesis since developing germ cells must migrate progressively from
the basal to the adluminal compartment but remain attached to the seminiferous epithelium, the physiological significance of Rho GTPases in
spermatogenesis remains largely unexplored. This paper reviews some recent findings on Rho GTPases in the field with emphasis on the
studies in the testis, upon which future studies can be designed to delineate the role of Rho GTPases in spermatogenesis.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Throughout spermatogenesis, developing germ cells
must translocate across the seminiferous epithelium while
differentiating into haploid spermatids. However, how are
these intriguing events of cell movement pertinent to sper-
matogenesis being regulated remain largely unknown (for
reviews, see Refs. [1–3]). Recent in vitro studies have
shown that cytokines, such as TGF-h2 and TGF-h3, can
perturb the assembly of the Sertoli cell tight junction (TJ)
permeability barrier in vitro [4]. Such TGF-h-induced
effects are possibly mediated by prohibiting the timely
expression of TJ-associated molecules such as occludin
and ZO-1 [4], which might be needed for assembling TJs
[5–8]. A more recent study has shown that TGF-h3 utilizes
the MEKKs/p38 signal transduction pathway to regulate the
Sertoli cell TJ-barrier [9]. Emerging evidence has shown
that the effects of growth factors, such as TGF-h, and other
molecules, such as a6h1 integrins, which constitute the
ectoplasmic specializations (a modified testis-specific cell–
cell actin-based adherens junction (AJ)) [10] that regulate
the cytoskeleton network and junction dynamics are medi-
ated by Rho GTPases (for reviews, see Refs. [1,3,11–13]).
This review summarizes an important and timely develop-
ment in the field. It also provides some crucial background
information on these regulatory molecules in the testis.
2. Molecular structure and members of Rho GTPases
Rho GTPases are monomeric G proteins with Mr ranging
between 20 and 40 kDa (for reviews, see Refs. [12,14]).
Rho GTPases are also members of the Ras superfamily (for
reviews, see Ref. [14]). The mammalian Rho GTPase family
consists of at least 10 distinctive proteins. These include
Rho (A, B and C isoforms), Rac (1 and 2 isoforms), Cdc42
(Cdc42Hs and G25K isoforms), RhoD, Rnd1/Rho6, Rnd2/
Rho7, Rnd3/Rho8, RhoG, TC10 and TTF (for reviews, see
Refs. [11,12,14]). Like other members of the Ras super-
family, Rho proteins act as molecular switches to control
various cellular processes by cycling between GTP-bound
(active) and GDP-bound (inactive) states mediated by
several regulatory proteins (see Fig. 1) (for reviews, see
Refs. [12,14]). Both RhoA [15], RhoB [16], Rac1 [17],
Rac2 [9], and Cdc42 [9,17] have been positively identified
in the testis by RT-PCR and/or immunohistochemistry. For
instance, RhoB, Rac2 and Cdc42 are known to be expressed
by Sertoli and germ cells [16,17]. Furthermore, several
effector proteins that regulate Rho GTPases have also been
identified in the testis by northerns and/or RT-PCR (see
Table 1). These results thus illustrate that the testis is
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equipped with the needed GTPases to regulate different
intracellular functions pertinent to junction dynamics and
cell movement.
3. Functions of Rho GTPases
Studies performed in the past two decades on Rho
GTPases using fibroblasts and keratinocytes in vitro have
shown that Rho GTPases are molecular switches that
regulate diversified cellular functions (for reviews, see Refs.
[12,14]). These include: (i) actin reorganization, (ii) junction
dynamics, (iii) cell movement, (iv) cell cycle, (v) cell
transformation, and (vi) gene transcription. Several recent
studies have shown that Rho GTPases are crucial molecules
that are pertinent to spermatogenesis. These results, in
context with the general functional role of Rho GTPases,
will be reviewed herein.
4. Regulatory proteins of Rho GTPases
The cycling between the GTP- and GDP-bound states in
Rho GTPases is regulated by three types of cellular proteins,
which include guanosine nucleotide exchange factors
(GEFs), GTPase-activating proteins (GAPs), and guanosine
nucleotide dissociation inhibitors (GDIs) (Fig. 1). GEFs
facilitate the exchange of GDP for GTP, which promotes
the binding of GTP to Rho GTPases activating the Rho
protein [11,18,19]. GAPs stimulate the intrinsic rate of GTP
hydrolysis of Rho GTPases converting their GTP-bound
state to GDP-bound state, inactivating Rho GTPases
[20,21]. GDIs appear to sequester GDP-bound Rho
GTPases in the cytoplasm and inhibit the dissociation of
GDP from Rho GTPases [22–24]. Ironically, the interplay
of these three regulatory proteins determines the level of
activated Rho GTPases within a cell, which in turn affects
the cytoskeleton network. A number of GEFs and GAPs that
regulate Rho GTPases have been identified, whereas only
three Rho GDIs are known, which include Rho GDIa, Rho
GDIh, and Rho GDIg (for reviews, see Ref. [11]) [24–27].
These regulators work synergistically, spatially and tempo-
rally to determine the level of GTP-bound Rho GTPases at
specific sites within a cell to regulate cellular function [11].
To date, at least one GDI called GDI-a [27] and five GAPs
[28–35] have been identified and characterized in the testis
(see Table 2). Most of these regulatory proteins, such as h-
chimaerin, are largely associated with germ cells. These
observations are somewhat intriguing since earlier studies
have implicated Sertoli cells are largely responsible for the
events of junction dynamics pertinent to cell movement in
the seminiferous epithelium (for reviews, see Refs. [1,2]).
The exclusive presence of these GTPases in germ cells
seemingly signifies that germ cells play a more active role
than originally anticipated to regulate their movement in the
seminiferous epithelium (see Tables 1 and 2). For instance,
h-chimaerin, a GAP, is a stage-specific protein largely
restricted to developing spermatids in the rat testis [31].
However, its precise role in spermatogenesis is not entirely
known since inhibitors specific to these GAPs are not yet
available. Furthermore, how these GAPs interact with Rho
GTPase to affect cellular function between Sertoli and germ
cells remains obscure.
5. Rho GTPase effector proteins
Using yeast two-hybrid system, affinity chromatography,
and ligand overlay assays, a number of Rho-interacting
proteins have been identified; their interactions with Rho
GTPases in turn regulate the functional status of the Rho
proteins [11]. To date, at least 15 Rho effector proteins have
been identified, such as ROCK1, ROCK2, Rhotekin, Rho-
kinase, and PIP 5-kinase (see Table 1). Recent studies have
identified both ROCK and p140mDia in the rat testis [16].
Once a Rho GTPase interacts with its corresponding effec-
tor, this complex can induce changes in actin polymer-
ization, focal adhesion, stress fiber formation, smooth
muscle contraction, neurite retraction, cytokinesis and other
cellular processes (see Table 1). Amongst these effector
proteins, at least seven have been positively identified in the
testis, some of which are putative protein kinases and lipid
Fig. 1. Cycling of Rho GTPases between GTP- (activated) and GDP-
(inactivated) bound state to regulate diversified cellular function. This event
is made possible via the interactions of Rho GTPases with different
regulators and effector proteins. Rho GDI dissociates from the GDP-bound
Rho GTPase, and GEF stimulates the exchange of GDP to GTP facilitating
the activation of Rho GTPase. The GTP-bound Rho GTPase interacts with
different effectors to affect different cellular functions. Furthermore, GAP
interacts with GTP-bound Rho GTPase and catalyzes the hydrolysis of GTP
from the complex. GDI, guanosine nucleotide dissociation inhibitor; GEF,
guanosine nucleotide exchange factor; GAP, GTPase activating protein.
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kinases (Table 1). Recent findings that demonstrate the
crucial roles of kinases and phosphatases in the regulation
of Sertoli cell TJ dynamics [36] further strengthen the notion
that these molecules are essential for cell movement.
6. Regulation of junction dynamics by Rho GTPases
6.1. Effects on tight junction (TJ) dynamics
Numerous studies have implicated the significance of
Rho GTPases in the regulation of TJ dynamics in different
cell types. For instance, ADP-ribosylation and inactivation
of Rho by C3 exoenzyme causes functional disruption of
TJs in T84 epithelial cells via ZO-1 redistribution, which
induces ZO-1 to move from the membrane at the sites of TJs
to cytosol [37]. Furthermore, constitutively active RhoA can
induce an increase in the tightness of TJs in MDCK cells,
which is mediated by Rho-associated kinase and a yet-to-be
identified Rho effector [38,39]. These two studies suggest
the crucial role of Rho in TJ dynamics in epithelial cells.
Apart from their direct effects on the TJ-integral mem-
brane proteins, there is increasing evidence demonstrating
that Rho GTPases regulate TJ integrity by altering actin
Table 1
Effector proteins for Rho
Effector
protein
Mr
(kDa)
Interacting
Rho protein
Type of protein Physiological function GTPase-
binding motif
Found in
the testis
References
ROCK1,
ROCK2
160 RhoA
RhoB
Ser/Thr kinase (i) actin organization;
(ii) stress fiber formation;
(iii) cell motility;
(iv) cytokinesis;
(v) focal adhesion
formation;
(vi) neurite retraction
RKH n.k. [68,70,96–107]
P140mDia 140 RhoA scaffold actin organization – + [106,108,109]
PKN 120 RhoA Ser/Thr kinase n.k. REM + [90,91,110,111]
PRK1,
PRK2
120 RhoA
RhoB
Ser/Thr kinase n.k. REM n.k. [112,113]
Citron
kinase
183 n.k. Ser/Thr kinase cytokinesis – n.k. [114,115]
MBS n.k. RhoA phosphatase MLC inactivation – n.k. [96]
Rhophilin 71 RhoA scaffold n.k. REM + [89,91]
Rhotekin 61 RhoA scaffold n.k. REM n.k. [116,117]
Kinectin 160 RhoA scaffold kinesin binding RKH + [118–120]
PLD 25 RhoA lipase regulate PA levels – + [121–127]
DAG kinase 78 RhoA lipid kinase regulate PA levels – + [128–131]
PI 4,5-
kinase
n.k. n.k. lipid kinase (i) actin organization;
(ii) regulate PIP2 level
– n.k. [78,129,132,133]
PI 3-kinase n.k. RhoA lipid kinase n.k. – + [134–137]
ROCK, Rho-associated protein kinase; p140mDia, mammalian homolog of diaphanous in Drosophila; PKN, protein kinase N; PRK1, PRK2, protein kinase C-
related kinase 1, 2; MBS, myosin-binding subunit; PLD, phospholipase D; DAG kinase, diacylglycerol kinase; PI 4,5-kinase, phosphatidylinositol-4-phosphate
5-kinase; PI 3-kinase, phosphatidyinositol-3-kinase; MLC, myosin light chain; PA, phosphatidic acid; PIP2, phosphatidylinositol 4,5-bisphosphate; RKH,
ROK-kinectin homology (also known as class-I Rho-binding motif); REM, Rho effector homology (also known as class-II Rho-binding motif); n.k., not
known; +, has been positively identified in the testis.
Table 2
GTPase activating proteins in the testis
GTPase activating protein
(GAP)
Mr
(kDa)
Target
GTPases
Species Localization and Function References
Rotund RacGAP (RnRacGAP) n.k. Rac, Cdc42 Drosophila
melanogaster
deletion of rn locus affects spermatid
differentiation; males are sterile
[28,29]
a2-Chimaerin 45 Rac rat mRNA found in the testis particularly in
pachytene spermatocytes
[30]
h-Chimaerin 34 Rac rat expresses exclusively in the testis at sexual
maturation; stage-specific expression parallel
to acrosomal assembly at late stage of
spermatogenesis
[31]
Male germ cell RacGAP
(MgcRacGAP)
58 Rac1, Cdc42 human specific expression of mgcRacGAP mRNA in
spermatocytes; interacts with Tat1, a sulfate
transporter, found in spermatocytes and
spermatids
[32,33]
Myr5 n.k. Rho rat found in lung, spleen, liver and testis [34,35]
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organization, thereby affecting TJ permeability. Nonethe-
less, the mechanism by which Rho GTPases regulate actin
organization is not fully characterized [40,41]. Yet, it is not
of interest to note that F-actin staining was shown to be
weak at the site of cell–cell contacts in MDCK cells
expressing dominant negative Rac1N17, but it was strong
in constitutively active Rac1V12 cells [42], whereas F-actin
staining was more intense at cell–cell contacts of overex-
pressed Rac1V12 and RacN17 cells versus control cells
[40]. These studies thus implicate the role of Rho GTPases
in actin reorganization in TJs. Cdc42 was also shown to play
an important role in the regulation of actin organization and
TJ function. For instance, MDCK cells expressing dominant
negative Cdc42N17 and dominant active Cdc42V12 are
having significantly lower resistance across the TJ-barrier,
suggesting Cdc42 regulates the gate function of TJ [43].
However, Rho GTPases, such as RhoB, Rac2 and Cdc42,
apparently are not involved in the assembly of Sertoli cell
TJ-barrier in vitro since an induction of their expression was
not detected during TJ-barrier assembly [9]. Yet, these
proteins may still be crucial to TJ dynamics in the testis
by affecting the actin cytoskeleton network.
6.2. Effects on cell–cell actin-based adherens junction (AJ)
dynamics
6.2.1. Rho GTPases found in AJs can affect cell
adhesiveness
Small Rho GTPases including Rac and Rho have been
found at the site of cell–cell contacts [40,42,44–46] and are
known to be involved in the regulation of cell adhesion
[47,48]. In keratinocytes, Rho and Rac are required for the
establishment and stabilization of cadherin-dependent cell–
cell adhesion and actin reorganization. Stable cadherin
adhesion failed to form when confluent patches of kerati-
nocytes microinjected with C3 exoenzyme or dominant
negative Rac (N17Rac) causing E-cadherin to move away
from the site of cell–cell contacts [47]. However, micro-
injection of constitutively active Rho (L63Rho) and Rac
(L61Rac) into confluent keratinocytes after AJs were
assembled did not perturb cadherins and failed to induce
cadherin recruitment to the site of cell–cell contacts. These
results thus suggest that the activation of Rho and Rac is
required for the establishment, but possibly not the main-
tenance, of stable cadherin-mediated cell adhesion [47]. It
was reported that the inhibition of endogenous Rho and Rac
can effectively remove P-cadherin from keratinocytes, how-
ever, it took a considerably longer incubation to remove E-
cadherin from the site of AJs [48]. These results seemingly
suggest that the ability of Rho and Rac in regulating cell
adhesiveness is dependent on the maturation status of the AJ
and the cell, as well as the class of cadherins [48]. Fur-
thermore, studies using human epidermal keratinocytes have
shown that cells having constitutively active Rac1 can
disrupt cell–cell contacts via clathrin-independent endocy-
tosis of E-cadherin and the ability of Rac1 to regulate AJ
disassembly is dependent on colony size [49,50]. Recent
studies have shown that AF-2364 [1-(2,4-dichlorobenzyl)-
indazole-3-carbohydrazide]-induced AJ disruption in the
testis, which causes premature release of germ cells from
the seminiferous epithelium [51,52], mediates its effect via
h1-, h2-integrin and h4-integrin [16,53] and testin [51,52]
(note: integrins were shown to be the putative cell adhesion
molecules in apical ectoplasmic specializations, a modified
testis-specific cell–cell actin-based AJ [10] that functionally
links to testin, an AJ-signaling molecule (for review, see
Ref. [3]) through a yet-to-be defined pathway). These
observations are crucial to the potential use of AF-2364
for male contraception because they explain why would AF-
2364 limit its effects in the testis inducing germ cell from
the seminiferous epithelium without damaging AJ structure
in other organs, such as liver and kidney [51,52] since the
a6h1 integrin/testin complex is unique to the ectoplasmic
specialization in the testis (for review, see Ref. [3]) and is
likely the target structure of AF-2364. Nonetheless, the
downstream signaling pathway mediated by integrin was
shown to be RhoB/ROCK/ LIMK [16] (Fig. 3). Taking
these results collectively, they clearly illustrate the pivotal
role of GTPases in AJ function in the testis.
6.2.2. Effects of Rho GTPases on AJ dynamics are cell
type-specific
The effect of GTPases on cell adhesion is also cell type-
specific. For instance, the activation of Rac can increase the
level of immunoreactive cadherin, h-catenin, and actin at
cell–cell borders in MDCK cells, suggesting that Rac may
strengthen cadherin-based adhesion [42,54,55]. However,
Rac activation failed to induce recruitment of cadherin to
AJs in human keratinocytes and HaCat cells (a keratinocyte
cell line) in contrast to MDCK cells [56]. More intriguingly,
sustained Rac activation in MDCK cells can specifically
remove cadherin from newly formed and stable cell–cell
contacts dose- and time-dependently [56]. Numerous studies
have revealed the complex roles of Rac1 in regulating AJ
dynamics, possibly mediated by two distinct regulatory
mechanisms [42,55,56]. Such a postulate is supported by
the observation that dominant active Rac expressed in
MDCK cells can either enhance or prevent E-cadherin-
mediated cell adhesion [57]. More research is needed to
resolve some of these apparently conflicting results that the
effects of Rho GTPases on AJ-protein recruitment are cell-
specific. Using Sertoli-germ cell cocultures in vitro to study
the events of Sertoli-germ cell AJ assembly, we have
demonstrated an induction of RhoB, Rac2 and Cdc42
mRNA levels when germ cells attach onto the Sertoli cell
epithelium, suggesting the potential role of Rho GTPases in
Sertoli-germ cell AJ assembly in the testis [16] (Lui and
Cheng, unpublished observations).
6.2.3. Mechanism of action
Regulation of AJ dynamics can be achieved through the
direct interaction of Rho GTPase and its effector proteins.
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For instance, IQGAP, is an effector protein that is involved
in regulating E-cadherin activity (for review, see Ref. [58]).
IQGAP is localized at the site of cell–cell contact, which
exerts negative regulatory effect on cadherin-mediated cell–
cell adhesion [59,60] (Fig. 2). This is achieved by direct
interaction of IQGAP with h-catenin causing the dissocia-
tion of a-catenin from the cadherin–catenin complexes
[60]. It was shown that Cdc42 and Rac1 are responsible
for regulating the IQGAP function by inhibiting the inter-
action between IQGAP and h-catenin, resulting in stabiliz-
Fig. 2. Regulation of E-cadherin-mediated cell –cell adhesion by IQGAP. Changes in cell adhesiveness is being regulated by altering the interactions between
IQGAP, h-catenin, and Rac and Cdc42. When IQGAP dissociates from Rac/Cdc42, it binds to the h-catenin of the cadherin–catenin complex, this in turn
destabilizes the cadherin–catenin complex, disrupting cell adhesion. Furthermore, this event is regulated in part by growth factors. This diagram was prepared
based on Refs. [11,58,95].
Fig. 3. A schematic drawing of different signaling pathways by which Rho GTPases regulate actin cytoskeleton network. The GTP-bound Rho is able to
activate different downstream effectors including ROCK, p140mDia, and PIP-5K. These effectors further regulate the corresponding downstream target
proteins, such as LIMK by ROCK, profilin by p140mDia, and PIP2 by PIP-5K via phosphorylation or direct protein–protein interactions. This in turn leads to
changes in actin filament organization. This figure was prepared based on Refs. [11,12,24].
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ing the cadherin–catenin complex [59]. Taking these results
collectively, it is clear that Rac and Cdc42 are important
regulators of cell adhesion. Using an in vivo model and
Sertoli-germ cell AJ disruption induced by AF-2364 [1-
(2,4)-dichlorobenzyl)-indazole-3-carbohydrazide] [51,52], it
was shown that the cascade of events leading to germ cell
loss from the epithelium involves an initial activation of
integrins and RhoB GTPase, which is followed by the
downstream activation of ROCK and LIMK [16]. This in
turn perturbs the actin cytoskeleton network that disrupts the
Sertoli-germ cell AJs.
7. Regulation of cell movement by Rho GTPases
Several studies have shown that Rho GTPases can be
regulated by growth factors and neurotransmitters [61–64].
This also provides the link between growth factor signaling
and the events of cell adhesion and cell movement via
reorganization of the actin filament network (for reviews,
see Refs. [65,66]).
Reorganization of actin filament, cell-substratum con-
tacts, and cell–cell adhesion are involved in cell movement.
Accumulating evidence has indicated that the Rho GTPase
family is involved in the reorganization of actin filament,
which in turn regulates cell movement. The functional roles
of Rho, Rac, and Cdc42, however, are different. For
instance, Rho regulates stress fiber formation [62]. Lamelli-
podia extension is regulated by Rac [61], and the activity of
filopodia is controlled by Cdc42 [63,67].
To understand how Rho GTPases regulate actin reorgan-
ization, intensive investigations were conducted to identify
specific effectors for Rho GTPases (Fig. 3). ROCKs, mDia
and PIP5-K are three crucial effectors that regulate Rho-
induced stress fiber assembly (for reviews, see Refs.
[11,24]). And both ROCKs and mDia are found in the rat
testis [16]. ROCKs (ROCK1 and ROCK2) are putative Ser/
Thr protein kinases, which contain a coiled–coiled region, a
ROK-kinectin homology (RKH) Rho-binding domain, a PH
domain, and a Cys-rich region [68,69]. ROCK has been
shown to phosphorylate the myosin-binding subunit (MBS)
of the myosin light chain (MLC) phosphatase [69,70].
LIMK, is another ROCK target protein. When LIMKs are
phosphorylated by ROCKs, the activated LIMK can inhibit
cofilin by phosphorylation, which in turn stabilizes the
filamentous actin structures [24,71,72].
mDia is the mammalian homologue of diaphanous in
Drosophila and a member of the formin-homology (FH)
family of proteins. It consists of three FH domains and a
small GTPase-binding domain (GBD) [73]. Multiple pro-
line-rich motifs in the FH1 domain bind to the G-actin-
binding protein known as profilin, their interactions lead to
the dissociation of actin from profilin that promotes actin
polymerization (for review, see Ref. [74]).
Rho also stimulates PIP 5-kinase and causes an elevation
of PIP2 levels [75]. High level of PIP2 dissociates gelsolin
and profilin from actin that contributes to actin reorganiza-
tion [76,77]. Besides, elevated PIP2 causes conformational
changes of vinculin, this enhances its binding ability to actin
and talin [78].
Apparently, these Rho downstream effectors are impor-
tant in actin reorganization, which in turn regulate cell
movement. However, very few studies have been done to
investigate the role of these effectors in the testis. Under-
standing the mechanism by which Rho GTPases regulate the
cellular cytoskeleton network will provide a useful guideline
of how to study the role of Rho GTPase effectors and their
functions in the testis.
8. Other biological functions of Rho GTPases
It is apparent that Rho GTPases also play a crucial role in
regulating other cellular processes that are dependent on the
actin cytoskeleton, such as phagocytosis [79,80], pinocyto-
sis [61], morphogenesis [81], cytokinesis [82,83], G1 cell
cycle progression [84] and cell transformation [18] (for
review, see Ref. [24]). Nonetheless, very few studies were
performed to explore their physiological functions in the
testis. For instance, Sertoli cells are the phagocytotic cells in
the testis that engulf residue bodies cast away from sperma-
tids during spermiation, and that eliminate apoptotic germ
cells during spermatogenesis [85,86]. Needless to say, Rho
GTPases may play a critical role in these events because
these processes are tightly integrated to the reorganization of
the cytoskeleton network. It is obvious that a thorough
understanding of Rho GTPases in these cellular events will
yield new insights in understanding their role(s) in sperma-
togenesis.
9. Current status of research in the testis
Studies by immunohistochemistry analysis have shown
that there is a strong staining of Rac1 at the basal compart-
ment of the seminiferous epithelium and its localization
appears to be predominant in stage VIII [17], Cdc42, how-
ever, is largely associated with spermatocytes and Sertoli
cells, and the most intense staining was detected surrounding
the heads of the elongated spermatids, still, it is not known if
Cdc42 is stage-specific [17]. These results seemingly suggest
that Rho GTPases are possibly involved in spermatogenesis,
yet, the mechanism or pathway by which they mediate their
effects are not known. An early study using C3 exoenzyme
has identified RhoA in the membrane of bovine sperm tail,
interestingly, its inactivation can lead to a decrease in sperm
motility [15]. To elucidate the function of Rho in the testis,
studies were performed to identify the downstream effector(s)
for Rho in the testis. Toshima et al. [87] reported the
identification of a novel protein kinase in the testis, TESK1,
which shares 50% homologywith LIMK, is largely expressed
by round spermatids. TESK1 was shown to stimulate the
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formation of integrin-mediated actin stress fibers and focal
adhesions via phosphorylation of cofilin [88]. Rhophilin is an
effector protein found in the testis associated with germ cells
undergoing meiosis, but not with somatic cells [89]. Rho
effectors, such as citron kinase and PKN, are also found in
testis, but their role(s), if any, is not known [90,91]. Other
studies were also performed to investigate the function of
Rho GTPase regulators, such as GAPs and GDls. For
instance, a2-chimaerin, h-chimaerin, and MgcRac are three
testis-specific GAPs largely restricted to germ cells and are
responsible for cytoskeleton reorganization [31,33,92] (Table
2). The significance of Rho GDIa in the testis has been
demonstrated in Rho GDIa /mice since  / male mice
were infertile with impaired spermatogenesis, the seminifer-
ous epithelium was devoid of spermatids and spermatocytes,
and vacuoles were found in the epithelium representing
degenerating germ cells [93]. Also, Limk2-deficient mice
were having impaired spermatogenesis and the Limk2 /
testes were smaller in size compared to normal mice [94]. The
seminiferous epithelium of Limk2 / testis contained few
spermatocytes in their early stage of development and the
number of germ cells beyond the pachytene stage were
greatly reduced versus normal mice [94].
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